Phreesia, Inc. (NYSE:PHR) Insider Yvonne Hui Sells 388 Shares

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 388 shares of the stock in a transaction on Friday, January 10th. The shares were sold at an average price of $27.85, for a total value of $10,805.80. Following the sale, the insider now owns 26,517 shares of the company’s stock, valued at $738,498.45. This trade represents a 1.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Yvonne Hui also recently made the following trade(s):

• On Tuesday, October 15th, Yvonne Hui sold 2,791 shares of Phreesia stock. The shares were sold at an average price of $20.92, for a total value of $58,387.72.

Phreesia Price Performance

Shares of NYSE PHR traded down $0.07 during midday trading on Monday, reaching $26.61. 434,990 shares of the company traded hands, compared to its average volume of 444,855. The stock’s 50-day simple moving average is $22.87 and its 200-day simple moving average is $22.63. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The firm has a market cap of $1.55 billion, a PE ratio of -18.10 and a beta of 0.94.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter in the previous year, the company posted ($0.58) earnings per share. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. As a group, equities analysts anticipate that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in PHR. International Assets Investment Management LLC raised its stake in shares of Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after acquiring an additional 1,395 shares during the last quarter. Lombard Odier Asset Management USA Corp bought a new position in Phreesia in the 2nd quarter worth approximately $202,000. Point72 DIFC Ltd acquired a new position in Phreesia during the 2nd quarter worth $209,000. XTX Topco Ltd bought a new position in Phreesia in the 3rd quarter valued at $247,000. Finally, Hsbc Holdings PLC bought a new stake in shares of Phreesia during the second quarter worth $301,000. 92.10% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Truist Financial raised their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Friday. JMP Securities restated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. Finally, Citigroup lifted their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia presently has an average rating of “Buy” and a consensus target price of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.